- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Mediators of Inflammation
Volume 2012 (2012), Article ID 717851, 13 pages
Anti-Inflammatory Effects of Adrenomedullin on Acute Lung Injury Induced by Carrageenan in Mice
1Department of Pharmacology, School of Pharmacy, University of Seville, 41012 Seville, Spain
2Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Torre Biologica, Policlinico Universitario, Via C. Valeria, Gazzi, 98100 Messina, Italy
3IRCCS Centro Neurolesi “Bonino-Pulejo”, S.S. 113 Via Palermo, CTR Casazza, 98100 Messina, Italy
4University of Manchester, Manchester M13 9PL, UK
Received 30 November 2011; Revised 8 March 2012; Accepted 19 March 2012
Academic Editor: Alex Kleinjan
Copyright © 2012 Talero Elena et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. Oliveira, R. A. Navarro-Xavier, E. A. Anjos-Vallota et al., “Effect of plant neutrophil elastase inhibitor on leucocyte migration, adhesion and cytokine release in inflammatory conditions,” British Journal of Pharmacology, vol. 161, no. 4, pp. 899–910, 2010.
- G. Matute-Bello, C. W. Frevert, and T. R. Martin, “Animal models of acute lung injury,” American Journal of Physiology, vol. 295, no. 3, pp. L379–L399, 2008.
- P. A. Ward, “Oxidative stress: acute and progressive lung injury,” Annals of the New York Academy of Sciences, vol. 1203, pp. 53–59, 2010.
- J. G. Wright and J. W. Christman, “The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy,” American Journal of Respiratory Medicine, vol. 2, no. 3, pp. 211–219, 2003.
- I. E. Wertz and V. M. Dixit, “Signaling to NF-κB: regulation by ubiquitination,” Cold Spring Harbor perspectives in Biology, vol. 2, no. 3, article a003350, 2010.
- K. Kitamura, K. Kangawa, M. Kawamoto et al., “Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma,” Biochemical and Biophysical Research Communications, vol. 192, no. 2, pp. 553–560, 1993.
- M. A. García, S. Martín-Santamaría, B. de Pascual-Teresa, A. Ramos, M. Julián, and A. Martínez, “Adrenomedullin: a new and promising target for drug discovery,” Expert Opinion on Therapeutic Targets, vol. 10, no. 2, pp. 303–317, 2006.
- E. Zudaire, S. Portal-Núñez, and F. Cuttitta, “The central role of adrenomedullin in host defense,” Journal of Leukocyte Biology, vol. 80, no. 2, pp. 237–244, 2006.
- S. Ueda, K. Nishio, N. Minamino, et al., “Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 1, pp. 132–136, 1999.
- J. Agorreta, J. J. Zulueta, L. M. Montuenga, and M. Garayoa, “Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS,” American Journal of Physiology, vol. 288, no. 3, pp. L536–L545, 2005.
- T. Itoh, H. Obata, S. Murakami et al., “Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats,” American Journal of Physiology, vol. 293, no. 2, pp. L446–L452, 2007.
- A. Martinez, M. J. Miller, E. J. Unsworth, J. M. Siegfried, and F. Cuttitta, “Expression of adrenomedullin in normal human lung and in pulmonary tumors,” Endocrinology, vol. 136, no. 9, pp. 4099–4105, 1995.
- Y. Yoshitomi, T. Nishikimi, S. Kojima et al., “Plasma levels of adrenomedullin in patients with acute myocardial infarction,” Clinical Science, vol. 94, no. 2, pp. 135–139, 1998.
- B. Cheung and R. Leung, “Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders,” Clinical Science, vol. 92, no. 1, pp. 59–62, 1997.
- B. B. Ceyhan, S. Karakurt, and N. Hekim, “Plasma adrenomedullin levels in asthmatic patients,” Journal of Asthma, vol. 38, no. 3, pp. 221–227, 2001.
- S. Sugo, N. Minamino, H. Shoji et al., “Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells,” Biochemical and Biophysical Research Communications, vol. 207, no. 1, pp. 25–32, 1995.
- E. Gonzalez-Rey, A. Chorny, N. Varela, G. Robledo, and M. Delgado, “Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response,” The American Journal of Pathology, vol. 168, no. 6, pp. 1921–1930, 2006.
- E. Gonzalez-Rey, A. Chorny, F. O'Valle, and M. Delgado, “Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells,” The American Journal of Pathology, vol. 170, no. 1, pp. 263–271, 2007.
- E. Talero, S. Sánchez-Fidalgo, C. A. de la Lastra, M. Illanes, J. R. Calvo, and V. Motilva, “Acute and chronic responses associated with adrenomedullin administration in experimental colitis,” Peptides, vol. 29, no. 11, pp. 2001–2012, 2008.
- A. J. Dwivedi, R. Wu, E. Nguyen et al., “Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion,” Journal of the American College of Surgeons, vol. 205, no. 2, pp. 284–293, 2007.
- S. Cuzzocrea, E. Mazzon, G. Calabro et al., “Inducible nitric oxide synthase—knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 5, pp. 1859–1866, 2000.
- S. Cuzzocrea, G. De Sarro, G. Costantino et al., “Role of interleukin-6 in a non-septic shock model induced by zymosan,” European Cytokine Network, vol. 10, no. 2, pp. 191–203, 1999.
- S. Cuzzocrea, D. P. Riley, A. P. Caputi, and D. Salvemini, “Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury,” Pharmacological Reviews, vol. 53, no. 1, pp. 135–159, 2001.
- K. M. Mullane, R. Kraemer, and B. Smith, “Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium,” Journal of Pharmacological Methods, vol. 14, no. 3, pp. 157–167, 1985.
- H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
- M. Delgado and D. Ganea, “Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents,” Brain, Behavior, and Immunity, vol. 22, no. 8, pp. 1146–1151, 2008.
- V. Motilva, E. Talero, J. R. Calvo, I. Villegas, C. Alarcón-de-la-Lastra, and S. Sánchez-Fidalgo, “Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities,” Current Pharmaceutical Design, vol. 14, no. 1, pp. 71–95, 2008.
- H. C. Müller, M. Witzenrath, T. Tschernig et al., “Adrenomedullin attenuates ventilator-induced lung injury in mice,” Thorax, vol. 65, no. 12, pp. 1077–1084, 2010.
- R. Di Paola, C. Crisafulli, E. Mazzon et al., “GW0742, a high-affinity PPAR -β/δ agonist, inhibits acute lung injury in mice,” Shock, vol. 33, no. 4, pp. 426–435, 2010.
- D. Impellizzeri, R. Di Paola, E. Esposito et al., “CGS 21680, an agonist of the adenosine receptor, decreases acute lung inflammation,” European Journal of Pharmacology, vol. 668, no. 1-2, pp. 305–316, 2011.
- S. Mukhopadhyay, J. R. Hoidal, and T. K. Mukherjee, “Role of TNFα in pulmonary pathophysiology,” Respiratory Research, vol. 7, article 125, 2006.
- D. Impellizzeri, E. Esposito, E. Mazzon et al., “The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy,” Clinical Nutrition, vol. 30, no. 4, pp. 533–540, 2011.
- C. Crisafulli, E. Mazzon, I. Paterniti, M. Galuppo, P. Bramanti, and S. Cuzzocrea, “Effects of Liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation,” Respiratory Research, vol. 11, article 19, 2010.
- C. Hesslinger, A. Strub, R. Boer, W. R. Ulrich, M. D. Lehner, and C. Braun, “Inhibition of inducible nitric oxide synthase in respiratory diseases,” Biochemical Society Transactions, vol. 37, no. 4, pp. 886–891, 2009.
- C. May, O. Williams, A. D. Milner et al., “Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia,” Archives of Disease in Childhood, vol. 94, no. 3, pp. F205–F209, 2009.
- M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006.
- H. Nakazawa, N. Fukuyama, S. Takizawa, C. Tsuji, M. Yoshitake, and H. Ishida, “Nitrotyrosine formation and its role in various pathological conditions,” Free Radical Research, vol. 33, no. 6, pp. 771–784, 2000.
- L. Virág, “Poly(ADP-ribosyl)ation in asthma and other lung diseases,” Pharmacological Research, vol. 52, no. 1, pp. 83–92, 2005.
- T. Genovese, E. Mazzon, R. Di Paola et al., “Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury,” Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 2, pp. 529–538, 2005.
- J. H. Kim, M. H. Suk, D. W. Yoon et al., “Inflammatory and transcriptional roles of poly (ADP-ribose) polymerase in ventilator-induced lung injury,” Critical Care, vol. 12, no. 4, article R108, 2008.
- A. Peralta-Leal, J. M. Rodríguez-Vargas, R. Aguilar-Quesada et al., “PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases,” Free Radical Biology and Medicine, vol. 47, no. 1, pp. 13–26, 2009.
- H. Matsui, T. Shimosawa, K. Itakura, X. Guanqun, K. Ando, and T. Fujita, “Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia,” Circulation, vol. 109, no. 18, pp. 2246–2251, 2004.
- S. M. Kim, J. Y. Kim, S. Lee, and J. H. Park, “Adrenomedullin protects against hypoxia/reoxygenation-induced cell death by suppression of reactive oxygen species via thiol redox systems,” FEBS Letters, vol. 584, no. 1, pp. 213–218, 2010.
- E. Gonzalez-Rey, A. Chorny, and M. Delgado, “Regulation of immune tolerance by anti-inflammatory neuropeptides,” Nature Reviews Immunology, vol. 7, no. 1, pp. 52–63, 2007.
- O. Pleguezuelos and S. Kapas, “Differentiation of the HaCaT keratinocyte cell line: modulation by adrenomedullin,” British Journal of Dermatology, vol. 154, no. 4, pp. 602–608, 2006.